These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 7583549

  • 1. Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Miserez AR, Keller U.
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1719-29. PubMed ID: 7583549
    [Abstract] [Full Text] [Related]

  • 2. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Pimstone SN, Defesche JC, Clee SM, Bakker HD, Hayden MR, Kastelein JJ.
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):826-33. PubMed ID: 9157944
    [Abstract] [Full Text] [Related]

  • 3. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H, Ninnis R, Miserez AR, Baumstark MW, Keller U.
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [Abstract] [Full Text] [Related]

  • 4. Familial defective apolipoprotein B-100.
    Hansen PS.
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [Abstract] [Full Text] [Related]

  • 5. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR, Martin FJ, Spirk D.
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [Abstract] [Full Text] [Related]

  • 6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 7. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia.
    Gaffney D, Forster L, Caslake MJ, Bedford D, Stewart JP, Stewart G, Wieringa G, Dominiczak M, Miller JP, Packard CJ.
    Atherosclerosis; 2002 May; 162(1):33-43. PubMed ID: 11947895
    [Abstract] [Full Text] [Related]

  • 8. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
    Myant NB, Gallagher JJ, Knight BL, McCarthy SN, Frostegård J, Nilsson J, Hamsten A, Talmud P, Humphries SE.
    Arterioscler Thromb; 1991 May; 11(3):691-703. PubMed ID: 1674216
    [Abstract] [Full Text] [Related]

  • 9. Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in maritime Canada.
    Morash B, Guernsey DL, Tan MH, Dempsey G, Nassar BA.
    Clin Biochem; 1994 Aug; 27(4):265-72. PubMed ID: 8001287
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.
    Ejarque I, Real JT, Martinez-Hervas S, Chaves FJ, Blesa S, Garcia-Garcia AB, Millan E, Ascaso JF, Carmena R.
    Transl Res; 2008 Mar; 151(3):162-7. PubMed ID: 18279815
    [Abstract] [Full Text] [Related]

  • 11. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
    Schewe CK, Schuster H, Hailer S, Wolfram G, Keller C, Zöllner N.
    Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
    [Abstract] [Full Text] [Related]

  • 12. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
    Ceska R, Vrablík M, Horínek A.
    Physiol Res; 2000 Jan; 49 Suppl 1():S125-30. PubMed ID: 10984082
    [Abstract] [Full Text] [Related]

  • 13. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW, Defesche JC, Kastelein JJ, Sijbrands EJ.
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
    Davignon J, Dufour R, Roy M, Bétard C, Ma Y, Ouellette S, Boulet L, Lussier-Cacan S.
    Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
    [Abstract] [Full Text] [Related]

  • 15. Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
    Tai ES, Koay ES, Chan E, Seng TJ, Loh LM, Sethi SK, Tan CE.
    Clin Chem; 2001 Mar; 47(3):438-43. PubMed ID: 11238294
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries.
    Hansen PS, Defesche JC, Kastelein JJ, Gerdes LU, Fraza L, Gerdes C, Tato F, Jensen HK, Jensen LG, Klausen IC, Faergeman O, Schuster H.
    Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):741-7. PubMed ID: 9108789
    [Abstract] [Full Text] [Related]

  • 17. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D, Schuster H, Zöllner N.
    Eur J Med Res; 1996 May 24; 1(8):383-6. PubMed ID: 9360938
    [Abstract] [Full Text] [Related]

  • 18. [DNA analysis in heterozygotes in familial hypercholesterolemia].
    Horínek A, Slézka V, Sobra J, Ceska R.
    Cas Lek Cesk; 1995 Apr 19; 134(8):234-9. PubMed ID: 7758080
    [Abstract] [Full Text] [Related]

  • 19. Familial hypercholesterolemia due to ligand-defective apolipoprotein B100: first case report in a Mexican family.
    Robles-Osorio L, Ordoñez ML, Aguilar-Salinas CA, Aurón-Gómez M, Tusié-Luna MT, Gómez-Pérez FJ, Rull-Rodrigo JA.
    Arch Med Res; 2003 Apr 19; 34(1):70-5. PubMed ID: 12604379
    [Abstract] [Full Text] [Related]

  • 20. [Clinical and biochemical characteristics of familial ligand-defective apo B-100 in a South European population].
    Ejarque I, Real JT, Chaves FJ, Blesa S, González V, Milian E, Ascaso JF, Priego MA, Carmena R.
    Med Clin (Barc); 2004 Oct 09; 123(12):456-9. PubMed ID: 15498441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.